SHAREHOLDERS’ EQUITY (Tables)
|
12 Months Ended |
Jul. 31, 2025 |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
SCHEDULE OF CHANGE IN FAIR VALUE OF WARRANTS |
SCHEDULE OF CHANGE IN FAIR VALUE OF WARRANTS
| |
Warrants
liability | |
| |
| |
Balance as of July 31, 2023 | |
| 29,139,301 | |
Fair value of BriaPro Warrant Shares at
Effective Date (note 1(e)) | |
| 199,207 | |
Change in fair value
during the year | |
| (28,242,472 | ) |
| |
| | |
Balance as of July
31, 2024 | |
$ | 1,096,036 | |
Change in fair value
during the year | |
| (758,364 | ) |
| |
| | |
Balance as of July
31, 2025 | |
$ | 337,672 | |
|
(*) |
Certain
warrants were issued prior to August 1, 2022 in respect of public offerings and private placements that contain terms that require
the warrants to be recorded as a liability at fair value under US GAAP. As a result, these warrants are valued at the end of each
reporting period. For the year ended July 31, 2025, the Company recorded a gain on the revaluation of the total warrant liability
of $758,364 in the consolidated statements of operations and comprehensive loss. |
|
|
|
|
|
The
key inputs used in the valuation of the of the warrant as of July 31, 2025 and at July 31, 2024 and on the issuance dates, were as
follows: |
|
SCHEDULE OF VALUATION OF PUBLIC OFFERING BROKER WARRANTS |
SCHEDULE
OF VALUATION OF PUBLIC OFFERING BROKER WARRANTS
| |
February
26, 2021 (Issuance
date) | | |
April
12, 2021 (Issuance
date) | | |
July
31, 2025 | | |
July
31, 2024 | |
| |
| | |
| | |
| | |
| |
Share price | |
$ | 510 | | |
$ | 588 | | |
$ | 7.50 | | |
$ | 112.50 | |
Exercise price | |
$ | 796.88 | | |
$ | 796.88 | | |
| 796.88-928.50 | | |
$ | 796.88-928.50 | |
Expected life (years) | |
| 5.00 | | |
| 5.00 | | |
| 0.57-1.35 | | |
| 1.57-2.35 | |
Volatility | |
| 100 | % | |
| 100 | % | |
| 157-209 | % | |
| 77-79 | % |
Dividend yield | |
| 0 | % | |
| 0 | % | |
| 0 | % | |
| 0 | % |
Risk free rate | |
| 0.88 | % | |
| 0.97 | % | |
| 4.10 | % | |
| 4.27 | % |
|
SCHEDULE OF BRIA PRO WARRANTS |
The
key inputs used in the valuation of the of the BriaPro Warrant Shares as of July 31, 2025 were as follows:
SCHEDULE
OF BRIA PRO WARRANTS
| |
| | |
August 31, | |
| |
July, 31 | | |
2023 | |
| |
2025 | | |
(Effective
Date) | |
| |
| | |
| |
Share price | |
$ | 0.0365 | | |
$ | 0.0365 | |
Exercise price | |
$ | 0.0206-0.0308 | | |
$ | 0.0206-0.0308 | |
Expected life (years) | |
| 0.30-1.35 | | |
| 2.21-3.27 | |
Volatility | |
| 157-209 | % | |
| 100 | % |
Dividend yield | |
| 0 | % | |
| 0 | % |
Risk free rate | |
| 2.68-2.74 | % | |
| 4.40 | % |
|
Share Purchase Warrants [Member] |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
SUMMARY OF CHANGES IN WARRANTS |
A
summary of changes in share purchase warrants for the years ending July 31, 2025 and 2024 is presented below:
SCHEDULE OF CHANGES IN WARRANTS
| |
Number
of options
outstanding | | |
Weighted
average
exercise
price (*) | |
Balance, July 31, 2023 | |
| 54,144 | | |
$ | 863.18 | |
Granted in the May 2024
Offering | |
| 16,019 | | |
| 316.50 | |
Balance, July 31, 2024 | |
| 70,163 | | |
$ | 738.36 | |
Exercised | |
| (6,437 | ) | |
| 127.50 | |
Granted in the October
2024 Offering | |
| 34,190 | | |
| 127.50 | |
Granted in the December
2024 Offering | |
| 49,333 | | |
| 140.63 | |
Granted in the April 2025
Offering | |
| 306,665 | | |
| 52.50 | |
Granted
in the July 2025 Offering | |
| 1,200,000 | | |
| 15.00 | |
Balance, July 31, 2025 | |
| 1,653,914 | | |
$ | 58.27 | |
|
SCHEDULE OF WARRANTS OUTSTANDING |
As
of July 31, 2025, warrants outstanding were as follows:
SCHEDULE OF WARRANTS OUTSTANDING
Number
of Warrants | | |
Exercise
Price | | |
Exercisable
At July 31, 2025 | | |
Expiry
Date |
| (*)346 | | |
$ | 588.62 | | |
| 346 | | |
November 16, 2025 |
| (*)25,978 | | |
$ | 796.88 | | |
| 25,978 | | |
February 26, 2026 – April 26, 2026 |
| (*)27,820 | | |
$ | 928.50 | | |
| 27,820 | | |
December 7, 2026 |
| 16,019 | | |
$ | 316.50 | | |
| 16,019 | | |
November 17, 2029 |
| 27,753 | | |
$ | 127.50 | | |
| 27,753 | | |
October 2, 2029 |
| 49,333 | | |
$ | 140.63 | | |
| 49,333 | | |
December 12, 2029 |
| 306,665 | | |
$ | 52.50 | | |
| 306,665 | | |
April 28, 2030 |
| 1,200,000 | | |
$ | 15 | | |
| 1,200,000 | | |
July 15, 2030 |
| 1,653,914 | | |
| | | |
| 1,653,914 | | |
|
(*) |
Briacell
Legacy Warrants – see note 1(d) and note 7(a) |
|
Compensation Warrants [Member] |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
SUMMARY OF CHANGES IN WARRANTS |
A
summary of changes in compensation warrants for the years ended July 31, 2025 and 2024 is presented below:
SUMMARY OF CHANGES IN WARRANTS
| |
Number
of warrants outstanding | | |
Weighted
average exercise
price (*) | |
Balance, July 31, 2023 | |
| 311 | | |
| 843.52 | |
Granted in the May 2024
Offering | |
| 333 | | |
| 348.00 | |
Balance, July 31, 2024 | |
| 644 | | |
| 587.30 | |
Granted in the September
2024 Offering | |
| 4,108 | | |
| 129.38 | |
Granted in the October
2024 Offering | |
| 1,709 | | |
| 182.81 | |
Granted in the December
2024 Offering | |
| 2,466 | | |
| 140.63 | |
Granted in the February
2025 Offering | |
| 3,812 | | |
| 50.00 | |
Granted
in the April 2025 Offering | |
| 15,333 | | |
| 52.50 | |
Balance, July 31, 2025 | |
| 28,072 | | |
$ | 91.35 | |
|
SCHEDULE OF WARRANTS OUTSTANDING |
As
of July 31, 2025, compensation warrants outstanding were as follows:
SCHEDULE OF WARRANTS OUTSTANDING
Number
of Warrants | | |
Exercise
Price | | |
Exercisable
At July 31, 2025 | | |
Expiry
Date |
| (*)34 | | |
$ | 588.62 | | |
| 34 | | |
November 16, 2025 |
| (*)113 | | |
$ | 796.88 | | |
| 113 | | |
February 26, 2026 |
| (*)164 | | |
$ | 928.50 | | |
| 164 | | |
June 7, 2026 |
| 333 | | |
$ | 348.00 | | |
| 333 | | |
May 17, 2029 |
| 4,108 | | |
$ | 129.38 | | |
| 4,108 | | |
September 12, 2029 |
| 1,709 | | |
$ | 182.81 | | |
| 1,709 | | |
October 2, 2029 |
| 2,466 | | |
$ | 140.63 | | |
| 2,466 | | |
December 12, 2029 |
| 3,812 | | |
$ | 50.00 | | |
| 3,812 | | |
February 5, 2030 |
| 15,333 | | |
$ | 56.50 | | |
| 15,333 | | |
April 28, 2030 |
| 28,072 | | |
| | | |
| 28,072 | | |
|
(*) |
Briacell
Legacy Warrants – see note 1(d) and note 7(a) |
|